An estimated 5.5 million Americans are currently living with Alzheimer’s disease. The symptoms of this debilitating illness include memory loss, agitation, mood swings, impaired judgment, difficulty handling money effectively, struggling with normal everyday tasks, confusion, misplacing things and difficulty communicating, among many others. The incredible strain this illness places on families and caregivers of those suffering with Alzheimer’s makes it understandable that many turn to antipsychotic drugs like haloperidol and risperidone to help to calm the affected person and make the condition more manageable.
A shocking new study by researchers at the University of Eastern Finland, published in the Journal of Alzheimer’s Disease, however, may have many families thinking twice about turning to these toxic drugs.
IOS Press reported:
Antipsychotic drug use is associated with a 60 percent increased risk of mortality among persons with Alzheimer’s disease, shows a recent study from the University of Eastern Finland. The risk was highest at the beginning of drug use and remained increased in long-term use. Use of two or more antipsychotic drugs concomitantly was associated with almost two times higher risk of mortality than monotherapy.
Read more: Treatment for Alzheimer’s can kill faster than the disease: Antipsychotic drugs found to increase risk of death